Acrivon Therapeutics, Inc. (ACRV) insider trading.
In Q3 2026, insiders at Acrivon Therapeutics, Inc. reported 10 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 9 sales worth $40K.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 9
- Net shares, P minus S
- -18,754
- Insiders
- 8
- Last filed
- 2026-09-02
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Masson Kristina / Blume-Jensen Peter | Director, Officer · EVP - Business Operations, President and CEO | 2 | 0 | 2 |
| Miller Mary | Officer · Chief Legal Officer | 2 | 0 | 2 |
| Levin Michaela | Officer · Chief Business Officer | 1 | 0 | 0 |
| Blume-Jensen Peter / Masson Kristina | Director, Officer · President and CEO, EVP - Business Operations | 1 | 0 | 1 |
| Devroe Eric | Officer · Chief Operating Officer | 1 | 0 | 1 |
| Gamelin Erick | Officer · Chief Development Officer | 1 | 0 | 1 |
| Peterson Katharine | Officer · Chief Accounting Officer | 1 | 0 | 1 |
| Levy Adam D. | Officer · Chief Financial Officer | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-31 | Levin Michaela | A (A) | 30,000 | $0 | 30,000 | Form 4 |
| 2026-08-25 | Blume-Jensen Peter / Masson Kristina | S (D) | 14,036 | $2.21 | 2,230,052 | Form 4 |
| 2026-08-18 | Masson Kristina / Blume-Jensen Peter | S (D) | 1,229 | $2.01 | 2,244,088 | Form 4 |
| 2026-08-18 | Masson Kristina / Blume-Jensen Peter | S (D) | 484 | $2.01 | 385,859 | Form 4 |
| 2026-08-18 | Devroe Eric | S (D) | 604 | $2.01 | 146,349 | Form 4 |
| 2026-08-18 | Gamelin Erick | S (D) | 400 | $2.01 | 52,592 | Form 4 |
| 2026-08-18 | Miller Mary | S (D) | 185 | $2.01 | 82,009 | Form 4 |
| 2026-08-18 | Peterson Katharine | S (D) | 101 | $2.01 | 18,033 | Form 4 |
| 2026-08-04 | Levy Adam D. | S (D) | 1,142 | $1.57 | 66,008 | Form 4 |
| 2026-07-21 | Miller Mary | S (D) | 573 | $1.76 | 82,194 | Form 4 |
Transaction codes in this quarter
Get ACRV insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1781174&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · ACRV company page · Acrivon Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Acrivon Therapeutics, Inc. (ACRV)?
In Q3 2026, insiders at Acrivon Therapeutics, Inc. reported 10 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 9 sales worth $40K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Acrivon Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/acrv.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.